期刊名称：ANDROLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Andrology
Instructions to Authors
Andrology Author Guidelines
Scope and Publication Policy
Andrology welcomes manuscript submissions on all aspects of andrology (male reproduction of humans and animals), including original and review articles, commentaries, letters and editorials in clinical and basic research. The journal will prioritize novelty, scientific quality and a broad interest of the readership. Case reports will not be considered unless containing substantial novel information.
Authors should adhere to the following minimal quality requirements:
- the number of study subjects should be sufficiently large to reach meaningful conclusions (for smaller genetic association studies the authors should provide power calculations)
- description of populations used in genetic and epidemiological studies must include age, gender, ethnicity, and geographic origin of subjects and controls
- clinical intervention studies must be pre-registered (see below) and include placebo or other controls
- each step of an original study should be properly controlled; both positive and negative controls should be included
- studies reporting data based on only one cell line will not be considered; cell lines should preferably be validated
- studies using antibodies must refer to previous validation. If new antibodies are used, a detailed characterisation must be included in the paper
- images should not be manipulated or duplicated from previous studies (except cited reprints used in review articles)
Submission is considered on the conditions that papers are previously unpublished, and are not offered simultaneously elsewhere; that all authors (defined below) have read and approved the content, and all authors have also declared all competing interests; and that the work complies with the Ethical Policies of Andrology, and has been conducted under internationally accepted ethical standards after relevant ethical review.
Please note that the journal employs a screening process in order to identify duplicate and redundant publication. By submitting your manuscript to the journal you accept that your manuscript may be screened for duplication against previously published work.
All articles submitted and accepted for publication in Andrology will be made freely available to all users 12 months after publication in an issue of the journal.
Andrology does not ask for publication or page charges from authors.
Ethics
The Journal upholds and expects the highest standards of conduct on the part of authors, peer referees, and editors. Manuscripts describing studies involving animals should comply with local/national guidelines governing the use of experimental animals and must contain a statement indicating that the procedures have been approved by the appropriate regulatory body (e.g. in the USA: The Guide for the Care and Use of Laboratory Animals prepared by the Institute of Laboratory Animal Resources for the National Research Council . Manuscripts concerned with human studies must contain statements indicating that informed, written consent has been obtained, that studies have been performed according to the Declaration of Helsinki, and that the procedures have been approved by a local ethics committee. If individuals might be identified from a publication (e.g. from images) authors must obtain explicit consent from the individual. The editors reserve the right not to accept papers unless adherence to the principles given in the Declaration of Helsinki and the Guiding Principles in the Care and Use of Animals (DHEW Publication, NIH) is clear.
The Journal’s ethical policies are outlined in the separate document Ethical Policies of Andrology. Submitted work must comply with these policies, which are based on the Committee on Publication Ethics (COPE) guidelines on good publication and comply with their Code of Conduct. Andrology is a member of the Committee on Publication Ethics.
Disclosures
Authors are required to disclose financial interests (e.g. employment, significant share ownership, patent rights, consultancy, research funding, etc.) in any company or institution that might benefit from their publication. All authors must provide details of any other potential competing interests of a personal nature that readers or editors might consider relevant to their publication. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. The statement should be placed in the text of the submitted manuscript directly following the Acknowledgements.
All sources of funding must be disclosed in the Acknowledgments section of the paper. Please list governmental, industrial, charitable, philanthropic and/or personal sources of funding used for the studies described in the manuscript. Attribution of these funding sources is preferred.
Example:
• This work was supported by a grant from the National Institutes of Health, USA (DKxxxx to AB).
Authorship
All authors must fulfil the following three criteria:
• Substantial contributions to research design, or the acquisition, analysis or interpretation of data
• Drafting the paper or revising it critically
• Approval of the submitted and final versions
The authors must indicate their specific contributions to the work described in the manuscript in the Authors' Contribution section, directly following the Acknowledgments. An author may list more than one contribution, and more than one author may have contributed to the same element of the work e.g. AB performed the research, AB & CD analyzed the data and wrote the paper, EF contributed the knockout mice for the study and GH designed the research study and wrote the paper.
Clinical trials (if applicable)
Clinical trials should be registered and publications must include the registration number and name of the trial register. If these are not available, please provide an explanation.
Submission and Review Process Manuscripts must be written in English (use consistently either British or American spelling) and must be submitted online. To submit, go to http://mc.manuscriptcentral.com/andrology . Full instructions for submission are detailed on this website.
All submitted articles are subject to review by two or more experienced referees. Authors are encouraged to suggest the names and email address of prospective reviewers. The names of undesired reviewers can also be stated.
Acceptance of manuscripts is based on scientific merit. The Editors will select and accept manuscripts suitable for publication - the Editors' decisions are final. Manuscripts accepted for publication are copyedited and typeset. The proofs are sent to contributors for a final check, but the cost of extensive changes to the proofs may be charged to the contributors.
Editorial and production queries: for manuscripts in the review process, please forward your query to Andy Beare at the editorial office (email: andrologyoffice@gmail.com).
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
OnlineOpen
Find out about the journal's open access option with OnlineOpen: OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee (US$3000) to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in PubMed Central. Making your article OnlineOpen increases its potential readership and enables you to meet institutional and funder open access mandates where they apply. Authors of OnlineOpen articles may immediately post the final, published PDF of their article on a website, institutional repository or other free public server. For the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below: CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
Note to NIH grantees. Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate
Format
Abstract Should be placed before the text of original articles and reviews. It should state at least the objectives, findings, and conclusions in a non-structured concise text (maximum 300 words).
Original studies should be clearly divided into the following sections: introduction; materials and methods; results; discussion with conclusions and references. Please remember to include acknowledgements (with funding information), disclosures, and author's contributions between the main text and reference list.
Abbreviations and units When first mentioned, cumbersome names should be suitably abbreviated for later reference in the paper. Doses of drugs should, if possible, be given as unit weight/body weight, e.g. nmol/kg. Concentrations can be given either in terms of molarity (e.g. nmol/l) or as ng/ml. The SI (Système International) units should be used. Molarity should refer to the active component.
In abbreviations and symbols, standardized terms should be used. Biochemical terminology should follow the recommendations in Biochemical Nomenclature and Related Documents, published by the Biochemical Society or the American Medical Association Manual of Style. For enzymes use the nomenclature recommended by IUPAC-IUB Commission as published in Enzyme Nomenclature, Academic Press, New York, 1980. Upon request authors can obtain a more complete list of abbreviations, units etc. from the publisher.
Whenever reference is made to unpublished work of others, a letter of permission from the responsible investigator should be included. Reference to work which is planned or in progress should be avoided.
Illustrations All figures must be submitted in electronic form. You can upload digital versions of figures when submitting your manuscript online. Number and a short caption should be indicated upon submission. Ideally, these should be sent in the PICT format if created on a Mac, or WMF if created in Windows. Files saved as PS, EPS, GIF and TIF may also be used, but please be aware that it will not be possible to modify them. Avoid using tints and 3-dimensional bars.
All photographs, drawings or graphs are referred to in the text as figures, abbreviated (Fig.), and should be numbered in sequence with Arabic numerals. Figures should be planned to fit a width of the printed column, 80 mm, 1½ column (120 mm) or two columns (165 mm). Labelling should be in minimum 8pt Helvetica or Arial. Figure sections should be designated with upper case letters. Magnification (scale) bars should be given on micrographs. Prominence of lettering, lines, curves, and signs should correspond to the relative importance of each component. Details of the magnification bar should be noted in the figure legends. The preferred place of each figure should be marked in the manuscript. If your paper is accepted, it is important that all electronic artwork is supplied to the editorial office in the correct format and resolution. We recommend that you consult the publisher's illustration guidelines at http://authorservices.wiley.com/bauthor/illustration.asp if you need advice on any aspect of preparing your artwork.
Colour Illustrations Authors of review articles will not be charged for colour work in their manuscript and therefore do not need to submit a colour work agreement form. Costs of colour illustrations for all other articles must be borne by the authors. If there is colour work in your manuscript when it is accepted for publication, Wiley-Blackwell require you to complete and return a colour work agreement form to the Production Editor (via fax: +65 6643 8008 or email: andrology@wiley.com) before your paper can be published. However, in exceptional circumstances, the Editors may choose to waive part or all of these costs if the authors are able to make a convincing case. The authors of accepted articles are encouraged to suggest one of the figures for inclusion on the cover of Andrology. The selected cover figure will be published in colour free of charge.
In the event that an author does not want or is not able to cover the costs of reproducing colour figures in colour in the printed version of the journal, Andrology offers authors the opportunity to reproduce colour figures in colour for free in the online version of the article (but they will still appear in black and white in the print version). If an author wishes to take advantage of this free colour-on-the-web service, they should complete and return the above colour work agreement form to the Production Editor.
Legends Each figure must have a corresponding legend. The legend must be numbered with an Arabic number that corresponds to the illustration as it appears in the text. Each should begin with a short title for the figure. Legends to figures should contain sufficient information to be understood without reference to the text but are not meant to repeat details of methodology. Explain all symbols, arrows, numbers, or letters used in the figure and provide information on scale and/or magnification. For photomicrographs, include information on the method of staining or preparation. Figure legends may be truncated in abbreviated links to the full screen version. Therefore, the first 100 characters of any legend should inform the reader of key aspects of the figure.
Tables These should be numbered consecutively in Arabic numerals and cited in the text. An approximate location in the text should be indicated in the left margin of the manuscript. Each table should have a legend which makes its general meaning comprehensible without reference to the text.
References We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting. The authors are responsible for the correctness of references. The references in the text should quote the surnames of the author/authors and the year of publication, 'Brown 1964', 'Brown & Smith (1968)' or (Brown et al. 1968) when there are more than two authors. The reference list should indicate only the publications mentioned in the text which should be listed in alphabetical order. List all authors if twenty or less. If more then 20 authors, list the first six and then add et al. et the last author or a group Titles of journals should be abbreviated according to the style used in Index Medicus.
Examples:
Monograph: Armitage P, Berry G & Matthews G. (2002) Statistical Methods in Medical Research (4th Edition), Blackwell Science, Oxford.
Single article: Corona G, Mannucci E, Forti G & Maggi M. (2009) Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl 32, 587–598.
Single article with more than 20 authors: Corona G, Wu FC, Forti G, Lee DM, O'Connor DB, O'Neill TW, et al. et EMAS Study Group (2012) Thyroid hormones and male sexual function. Int J Androl 35, 668-679.
Book chapter: Cooke PS, Sato T & Buchanan DL. (2001) Disruption of steroid hormone signaling by PCBs. In: PCBs: Recent Advances in Environmental Toxicology and Health Effects (eds L W Robertson & L G Hanson), pp. 257–263.The University Press of Kentucky, Kentucky.
Review Articles Andrology will publish review articles on subjects pertinent to all aspects of andrology. The Editors will solicit these reviews; unsolicited reviews are also welcome but only from authors with a strong track record in the field of the review. Organizers of international meetings relevant to andrology may also contact the editors for publishing the meeting proceedings. Both solicited and unsolicited reviews and proceedings will undergo the same editorial refereeing process as original manuscripts. Reviews are limited to 20-36 double-spaced, typed pages including a maximum of 200 references. Although authors of Reviews are exempt from colour figure charges, to keep publication costs contained they are encouraged only to use colour in figures where necessary.
Letters to the Editor and Commentaries These are subject to critical review by editors or additional reviewers, if necessary, and may be published in part or in full. Preference is given to letters related to articles published in the Journal, but letters or commentaries on topics of current interest (including bio-ethical aspects) may be accepted if space is available. Letters are restricted to 600 words and five references. Commentaries may contain up to 1200 words and may contain one figure or table. Commentaries on the careers of recently deceased significant members of the andrology community (marked Memorials) as well as tributes to major figures in the history of andrology will also be considered.
Proofs The corresponding author will receive an e-mail alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Authors will be charged for any major changes against the manuscript, and excessive changes may be disallowed. If a significant amount of new material is added, the paper may be re-reviewed by the Editors and re-dated. Second proofs will be sent only if justifiably requested by the author. Final proofs are read by the Editorial Office and – only in problematic cases - by the Editors.
Offprints The corresponding author will be able to download the PDF offprints of their article via Author Services after it is published in print. Printed offprints can be supplied if ordered through http://offprint.cosprinters.com/cos/
Supporting Information Andrology will consider inclusion of supporting information such as figures, methodological details and video clips not exceeding 15Mb. Supporting information should not be required for the full and complete understanding of the paper. Any material that is required for the full and complete understanding of the paper should either be incorporated fully into the paper or referred to in some other manner such as traditional reference, appendix or reference to an author-hosted website. Further details on submitting supporting information can be found at http://authorservices.wiley.com/bauthor/suppmat.asp
Author Material Archive Policy Unless specifically requested, Wiley-Blackwell will dispose of all hardcopy or electronic material submitted four months after publication. If you require return of any material submitted, please inform the Editorial Office or Production Editor on submission.
Early View Andrology is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue (see below). After print publication, the DOI remains valid and can continue to be used to cite and access the article.
Citing online articles The Journal encourages citation of online articles before they are published in final form when they become available in PubMed or from journal/publisher websites, e.g. Early View articles from the Andrology website. The citation must take the following form: Author(s), Title, Journal, Year; in press (DOI). Any article that lacks a year of publication or a DOI will not be considered a valid reference citation and cannot be cited.
Online production tracking is now available for your article through Wiley-Blackwell’s Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don’t need to contact the production editor to check on progress. Visit authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Disclaimer The Publisher, American Society of Andrology, European Academy of Andrology and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher, European Academy of Andrology, American Society of Andrology and Editors, neither does the publication of advertisements constitute any endorsement by the Publisher, American Society of Andrology, European Academy of Andrology and Editors of the products advertised.
Editorial Board
Editors in Chief
Ewa Rajpert-De Meyts, Dept. of Growth & Reproduction, Copenhagen University Hospital (Rigshospitalet), Section GR-5064, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark
Douglas T. Carrell, Departments of Surgery (Urology), Obstetrics and Gynecology, and Human Genetics, University of Utah School of Medicine, UT, USA
Associate Editors
R. John Aitken, Biological Sciences, University of Newcastle, Callaghan, NSW, Australia
John Amory, Center for Research in Reproduction and Contraception, University of Washington, Seattle, USA
Tadashi Baba, Faculty of Life & Environmental Sciences, University of Tsukuba, Ibaraki, Japan
Elisabetta Baldi, University of Florence, Florence, Italy
Arthur Burnett, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
Gail Cornwall, Texas Tech University Health Sciences Center, Lubbock, TX, USA
Gert Dohle, Erasmus University Medical Center, Rotterdam, The Netherlands
Aleksander Giwercman, Reproductive Medicine Center, Malmö, Sweden
Kate L. Loveland, School of Biomedical Sciences, Monash University, Clayton, Vic, Australia
Peter J. O'Shaughnessy, Institute of Biodiversity, Animal Health & Comparative Medicine, University of Glasgow, Glasgow, Scotland, UK
Gail Prins, Dept. Of Urology, University of Illinois at Chicago, Chicago, IL, USA
Rodolfo Rey, Centro de Investigaciones Endocrinologicas, Hospital de Niños R. Guttierez, Buenos Aires, Argentina
Armand Zini, McGill University, Montreal, Quebec, Canada
Michael Zitzmann, Centre for Reproductive Medicine and Andrology, University of Münster, Münster, Germany
Editorial Board
Ashok Agarwal, Cleveland, Ohio, USA
Jacques Auger, Paris, France
Janice L. Bailey, Québec, Canada
Susan Benoff, Manhaseet, New York, USA
Lars Björndahl, Stockholm, Sweden
Nancy Brackett, Miami, Florida, USA
C. Yan Cheng, New York, New York, USA
Don Conrad, St Louis, Missouri, USA
Patricia Cuasnicú, Buenos Aires, Argentina
Joel Drevet, Clermont-Ferrand, France
Ahmed El-Sakka, Ismailia, Egypt
Juris Erenpreiss, Riga, Latvia
Alberto Ferlin, Padova, Italy
Luiz R. Franca, Belo Horizonte, Brazil
Sandro Francavilla, L’Aquila, Italy
Dimitrios G. Goulis, Thessaloniki, Greece
Trine B. Haugen, Oslo, Norway
Wayne J. G. Hellstrom, New Orleans, Louisiana, USA
Ralf Henkel, Bellville, South Africa
Rex Hess, Urbana, Illinois, USA
Barry Hinton, Charlottesville, Virginia, USA
Ilpo Huhtaniemi, London, UK and Turku, Finland
Emmanuele A. Jannini, L’Aquila, Italy
Ates Kadioglu, Istanbul, Turkey
Wilma Kempinas, Botucatu, Brazil
Csilla Krausz, Florence, Italy
Krzysztof Kula, Lodz, Poland
Dolores Lamb, Houston, Texas, USA
Yvonne Lundberg Giwercman, Malmö / Lund, Sweden
Con Mallidis, Münster, Germany
Peter Liu, Sydney, NSW, Australia
Robert McLachlan, Melbourne, VIC, Australia
Ajay Nangia, Kansas City, Kansas, USA
Rajesh K. Naz, Morgantown, West Virginia, USA
Moira O’Bryan, Melbourne, VIC, Australia
Rafael Oliva, Barcelona, Catalonia, Spain
Bhudan Pukazhenthi, Front Royal, Virginia, USA
Stefan Schlatt, Münster, Germany
Lee Smith, Edinburgh, Scotland, UK
Peter Sutovsky, Columbia, Missouri, USA
Katja Teerds, Wageningen, The Netherlands
Jorma Toppari, Turku, Finland
Jacquetta Trasler, Montreal, Canada
Jacques Tremblay, Quebec City, Canada
Paul Turek, San Francisco, California, USA
D.N. Rao Veeramachaneni, Fort Collins, Colorado, USA
Tom Walsh, Seattle, Washington, USA
Monika Ward, Honolulu, Hawaii, USA
Steven Ward, Honolulu, Hawaii, USA
Wolfgang Weidner, Giessen, Germany
|
刊名字顺( Alphabetical List of Journals):
返回页首 